News and Announcements
Video: iComplii Founder and CEO Jason Knight Featured on Ventured
- Published July 18, 2016 12:48PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
iCompLii Founder and CEO Jason Knight talks about being the founder of iCompLii, some of the pains and also the gains. iCompLii is changing the way compliance is managed at both a personal and business level by removing the risks.
ABOUT ICOMPLII
iCompLii is revolutionising compliance for individuals and businesses with portable profiles for both human and physical assets, allowing flexibility and more certainty in workplaces that are becoming more contingent and a decreasing average length of employment.
The highly developed SaaS cloud-based platform handles the administration burden of complying with regulations and offers a service to candidates which enables them to efficiently store and manage all their personal and working information (including skills and certificates). iCompLii already has over 18,000 profile holders register since the platform was opened to the public in mid January 2016.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
